Tanjak, Pariyada <br/><br/>
Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors.  [electronic resource] 

 -  International journal of oncology  Jul 2018 
 - 177-188 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2018.4375  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cholangiocarcinoma--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Estrogen Receptor beta--agonists<br/>Estrogens--metabolism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genistein--administration & dosage<br/>Humans<br/>Interleukin-6--genetics<br/>Oncogene Protein v-akt--antagonists & inhibitors<br/>Phosphorylation<br/>Signal Transduction--drug effects